Using the science of psychosocial care to implement the New American College of Surgeons Commission on Cancer distress screening standard

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 11, Issue 2, 2013, Pages 214-221

  Wagner, Lynne I ^a   Spiegel, David ^b   Pearman, Timothy ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY DISORDER; BREAST METASTASIS; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; DEPRESSION; DISTRESS SYNDROME; ELECTRONIC MEDICAL RECORD; EMERGENCY HEALTH SERVICE; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE QUALITY; HUMAN; MEDICAL INFORMATICS; MOOD DISORDER; PRACTICE GUIDELINE; PSYCHOSOCIAL CARE; QUESTIONNAIRE; REVIEW; SCREENING; SELF REPORT; SUICIDAL IDEATION;

EID: 84874637205     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2013.0028     Document Type: Review

References (53)

1. American College of Surgeons Commission on Cancer. Cancer Program Standards 2012, Version 1.1: Ensuring Patient-Centered Care. Available at: http://www.facs.org/cancer/coc/programstandards2012.html. Accessed January 2, 2013.
2. Holland JC, Andersen B, Breitbart WS, et al. Distress management. J Natl Compr Canc Netw 2010;8:448-485.
3. Wagner LI. Cancer Program Standards 2012 Continuum of Care Services: focus on psychosocial distress screening, tools and resources [webinar]. November 30, 2011. Available at: http://www.facs.org/cancer/cocflash/2012/march. html. Accessed January 2, 2013.
4. Jacobsen PB, Holland JC, Steensma DP. Caring for the whole patient: the science of psychosocial care. J Clin Oncol 2012;30:1151-1153.
5. Carlson LE, Groff SL, Maciejewski O, Bultz BD. Screening for distress in lung and breast cancer outpatients: a randomized controlled trial. J Clin Oncol 2010;28:4884-4891.
6. Adler NE, Page A, eds. Cancer care for the whole patient: meeting psychosocial health needs. Washington, DC: National Academies Press; 2008.
7. Jacobsen PB, Ransom S. Implementation of NCCN distress management guidelines by member institutions. J Natl Compr Canc Netw 2007;5:99-103.
8. Giese-Davis J, Collie K, Rancourt KM, et al. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 2011;29:413-420.
9. Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK. Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med 2009;169:1274-1281.
10. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 2006;24:5132-5137.
11. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology 2001;10:19-28.
12. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-1744.
13. Dupont A, Wheeler J, Herndon JE II, et al. Use of tablet personal computers for sensitive patient-reported information. J Support Oncol 2009;7:91-97.
14. Abernethy AP, Zafar SY, Wheeler JL, et al. Electronic patient-reported data capture as a foundation of rapid learning cancer care. Med Care 2010;48(6 Suppl):S32-38.
15. Clark K, Bardwell WA, Arsenault T, et al. Implementing touch-screen technology to enhance recognition of distress. Psychooncology 2009;18:822-830.
16. Miller MF, Buzaglo JS, Clark KL, et al. Demonstrating the psychometric properties of a problem-related distress screener in a community sample of 319 cancer survivors. Psychooncology, in press.
17. Loscalzo M, Clark K, Dillehunt J, et al. Support Screen: a model for improving patient outcomes. J Natl Compr Canc Netw 2010;8:496-504.
18. Butt Z, Wagner LI, Beaumont JL, et al. Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manage 2008;35:20-30.
19. Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Onol 2007;25:4670-4681.
20. Mitchell AJ. Short screening tools for cancer-related distress: a review and diagnostic validity meta-analysis. J Natl Compr Canc Netw 2010;8:487-494.
21. Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008. J Clin Epidemiol 2010;63:1179-1194.
22. Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol 2012;30:1160-1177.
23. Johnson TV, Garlow SJ, Brawley OW, Master VA. Peak window of suicides occurs within the first month of diagnosis: implications for clinical oncology. Psychooncology 2012;21:351-356.
24. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269-282.
25. Kissane DW, Grabsch B, Love A, et al. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Austr N Z J Psychiatry 2004;38:320-326.
26. McDaniel JS, Musselman DL, Porter MR, et al. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 1995;52:89-99.
27. Hotopf M, Chidgey J, Addington-Hall J, Ly KL. Depression in advanced disease: a systematic review part 1. Prevalence and case finding. Palliat Med 2002;16:81-97.
28. Chochinov HM. Depression in cancer patients. Lancet Oncol 2001;2:499-505.
29. Kessler RC, Petukhova M, Sampson NA, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res 2012;21:169-184.
30. Miller AH, Ancoli-Israel S, Bower JE, et al. Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol 2008;26:971-982.
31. Akechi T, Okuyama T, Onishi J, et al. Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev 2008:CD005537.
32. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009;115:5349-5361.
33. Cohen L, Cole SW, Sood AK, et al. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One 2012;7:e42324.
34. Penninx BW. Chronically depressed mood and cancer risk in older persons. J Natl Cancer Inst 1998;90:1888-1893.
35. Giese-Davis J, Collie K, Rancourt KM, et al. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 2011;29:413-420.
36. Spiegel D. Mind matters in cancer survival. JAMA 2011;305:502-503.
37. Manning M, Bettencourt BA. Depression and medication adherence among breast cancer survivors: bridging the gap with the theory of planned behaviour. Psychol Health 2011;26:1173-1187.
38. Ancoli-Israel S, Liu L, Marler MR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 2006;14:201-209.
39. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 2000;92:994-1000.
40. Bock M, Moore D, Hwang J, et al. The impact of an electronic health questionnaire on symptom management and behavior reporting for breast cancer survivors. Breast Cancer Res Treat 2012;134:1327-1335.
41. Abernethy AP, Herndon JE, Wheeler JL, et al. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/tablet data-collection system in academic oncology. J Pain Symptom Manage 2009;37:1027-1038.
42. Abernethy AP, Wheeler JL, Zafar SY. Management of gastrointestinal symptoms in advanced cancer patients: the rapid learning cancer clinic model. Curr Opin Support Palliat Care 2010;4:36-45.
43. Carlson LE, Groff SL, Bultz BD, et al. Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: Randomised controlled trial of computerised vs personalised triage. Br J Cancer 2012;107:617-625.
44. Chan CW, Tam W, Cheng KK, et al. Piloting electronic self report symptom assessment - Cancer (ESRA-C) in Hong Kong: a mixed method approach. Eur J Oncol Nurs 2011;15:325-334.
45. Bennett AV, Basch E, Jensen RE. Electronic patient-reported outcome systems in oncology clinical practice. CA Cancer J Clin 2012;62:336-347.
46. Pilkonis PA, Choi SW, Reise SP, et al. Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS): depression, anxiety, and anger. Assessment 2011;18:263-283.
47. Gershon R, Rothrock NE, Hanrahan RT, et al. The development of a clinical outcomes survey research application: Assessment Center. Qual Life Res 2010;19:677-685.
48. Wagner LI, Abraham L, King K, et al. Integrating the Patient-Reported Outcomes Measurement Information System symptom assessment into routine cancer care [abstract]. Med Decis Making 2012;32:Abstract 7163.
49. Cohen MZ, Easley MK, Ellis C, et al. Cancer pain management and the JCAHO's pain standards: an institutional challenge. J Pain Symptom Manage 2003;25:519-527.
50. Frasco PE, Sprung J, Trentman TL. The impact of the joint commission for accreditation of healthcare organizations pain initiative on perioperative opiate consumption and recovery room length of stay. Anesth Analg 2005;100:162-168.
51. Jacobsen PB, Wagner LI. A new quality standard: the integration of psychosocial care into routine cancer care. J Clin Oncol 2012;30:1154-1159.
52. Loscalzo M, Clark KL, Holland J. Successful strategies for implementing biopsychosocial screening. Psychooncology 2011;20:455-462.
53. Bultz BD, Groff SL, Fitch M, et al. Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psychooncology 2011;20:463-469.